Clearmind Medicine CMND
NASDAQ CMND
$1.74 +0.01 (+0.87%)
At close: Aug 21, 2026 · 4:00 PM EDT

Clearmind Medicine (CMND) EBT Growth (3y) (2025 - 2026)

Clearmind Medicine (CMND) EBT Growth (3y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 6.22%
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 12.16%
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 103.69%
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 24.03%
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 41.79%
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 38.36%
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -27.69%
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 64.03%
9 Royalty Pharma 27.27 Bn 26.43 Bn - -38.56%
10 Clearmind Medicine 537,435.54 -13.06 Mn - -10.20%

Historic Data

Download Data
DateValue
Apr 30, 2026 -10.20%
Jan 31, 2026 -26.64%
Oct 31, 2025 21.89%
Jul 31, 2025 4.16%
Apr 30, 2025 25.37%
Jan 31, 2025 14.51%